GATA2 |
K562 (myelogenous leukemia) |
bio |
Permissive
Robust
|
Homo sapiens |
GSE29195
...
|
MA0036.3
|
GATA2 |
G1E-ER4 (embryonic stem cells) |
E2 |
Permissive
|
Mus musculus |
GSE30142
...
|
MA0036.3
|
GATA2 |
G1E-ER4 (embryonic stem cells) |
24 hours differentiation of G1E-ER4 cells with 10 nM beta-estradiol (Hardison) |
Permissive
|
Mus musculus |
ENCSR000DID
...
|
MA0036.3
|
GATA2 |
uterus |
P4 |
Permissive
Robust
|
Mus musculus |
GSE40659
...
|
MA0036.3
|
GATA2 |
embryonic stem cell-derived hemangioblasts |
none |
Permissive
|
Mus musculus |
GSE69099
...
|
MA0036.3
|
GATA2 |
embryonic stem cell-derived hematopoietic progenitors |
none |
Permissive
|
Mus musculus |
GSE69099
...
|
MA0036.3
|
GATA2 |
Lhx2 (hematopoietic stem cells) |
TGFb |
Permissive
Robust
|
Mus musculus |
GSE73641
...
|
MA0036.3
|
GATA2 |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
RUNX1-EVI1 KD |
Permissive
Robust
|
Homo sapiens |
GSE87283
...
|
MA0036.3
|
GATA2 |
WA09 (embryonic stem cells) |
BMP4 for 3 day |
Permissive
|
Homo sapiens |
GSE105081
...
|
MA0036.3
|
GATA2 |
WA09 (embryonic stem cells) |
BMP4 for 3 day |
Permissive
Robust
|
Homo sapiens |
GSE105081
...
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 0 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 1 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 4 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
Treatment: agent VEGF, timepoint 12 Passage: P3-6 |
Permissive
Robust
|
Homo sapiens |
GSE109625
...
|
MA0036.3
|
GATA2 |
3T3-L1 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
GATA2 |
3T3-L1 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
GATA2 |
C3H10T1/2 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
GATA2 |
C3H10T1/2 (embryonic fibroblasts) |
PAssage: 4-6 |
Permissive
Robust
|
Mus musculus |
GSE101592
...
|
MA0036.3
|
GATA2 |
TF-1 (erythroleukemia) |
Genotype: wildtype; Treatment: DOX for 6 days; |
Permissive
Robust
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
GATA2 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
GATA2 |
TF-1 (erythroleukemia) |
Genotype: TF-1-RAD21 Q592*; Treatment: DOX for 6 days; |
Permissive
|
Homo sapiens |
GSE73207
...
|
MA0036.3
|
GATA2 |
ME-1 (acute myeloid leukemia ) |
Treatment: 600 ng/ml doxycycline; Genotype: CBFB-MYH11 knockdown construct, GATA2 knockdown; |
Permissive
|
Homo sapiens |
GSE117138
...
|
MA0036.3
|
GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000BKM
|
MA0036.3
|
GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000DKA
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EVW
|
MA0036.3
|
GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EWG
|
MA0036.3
|
GATA2 |
SH-SY5Y (neuroblastoma) |
|
Permissive
Robust
|
Homo sapiens |
ENCSR000EYB
|
MA0036.3
|
GATA2 |
Lin- bone marrow hematopoietic progenitor cells |
|
Permissive
Robust
|
Mus musculus |
GSE26031
...
|
MA0036.3
|
GATA2 |
embryonic stem cell-derived haematopoietic cells |
|
Permissive
Robust
|
Mus musculus |
GSE22178
...
|
MA0036.3
|
GATA2 |
megakaryocytes |
|
Permissive
Robust
|
Homo sapiens |
GSE24674
...
|
MA0036.3
|
GATA2 |
G1E (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE29193
...
|
MA0036.3
|
GATA2 |
K562 (myelogenous leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE18868
...
|
MA0036.3
|
GATA2 |
HUVEC-C (HUVEC, umbilical vein endothelial cells) |
|
Permissive
Robust
|
Homo sapiens |
GSE29531
...
|
MA0036.3
|
GATA2 |
G1E (embryonic stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE30142
...
|
MA0036.3
|
GATA2 |
G1E (embryonic stem cells) |
|
Permissive
|
Mus musculus |
ENCSR000DIE
...
|
MA0036.3
|
GATA2 |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE42518
...
|
MA0036.3
|
GATA2 |
G1ME (megakaryocyte progenitor cell line) |
|
Permissive
Robust
|
Mus musculus |
GSE31331
...
|
MA0036.3
|
GATA2 |
CD34+ hematopoietic stem cells |
|
Permissive
Robust
|
Homo sapiens |
GSE45144
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
FDCP-Mix (multipotent stem cells) |
|
Permissive
Robust
|
Mus musculus |
GSE50406
...
|
MA0036.3
|
GATA2 |
mast cells |
|
Permissive
Robust
|
Mus musculus |
GSE48085
...
|
MA0036.3
|
GATA2 |
416B (hematopoietic precursor cells) |
|
Permissive
Robust
|
Mus musculus |
GSE69776
...
|
MA0036.3
|
GATA2 |
Kasumi-3 (adult acute myeloid leukemia with minimal differentiation) |
|
Permissive
Robust
|
Homo sapiens |
GSE84782
...
|
MA0036.3
|
GATA2 |
Kasumi-1 (acute myeloblastic leukemia) |
|
Permissive
|
Homo sapiens |
GSE76464
...
|
MA0036.3
|
GATA2 |
Hoxb8-FL |
|
Permissive
Robust
|
Mus musculus |
GSE84328
...
|
MA0036.3
|
GATA2 |
SKH1 (chronic myelogenous leukemia, BCR-ABL1 positive) |
|
Permissive
Robust
|
Homo sapiens |
GSE87283
...
|
MA0036.3
|
GATA2 |
endometrial stromal cells |
|
Permissive
Robust
|
Homo sapiens |
GSE108408
...
|
MA0036.3
|
GATA2 |
HL-60 (acute myeloid leukemia) |
|
Permissive
|
Homo sapiens |
ERP008568
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE38391
|
MA0036.3
|
GATA2 |
ME-1 (acute myeloid leukemia ) |
|
Permissive
|
Homo sapiens |
GSE46044
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
|
Permissive
Robust
|
Homo sapiens |
GSE52725
|
MA0036.3
|
GATA2 |
TSU-1621-MT (adult acute myeloid leukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE60477
|
MA0036.3
|
GATA2 |
TF-1 (erythroleukemia) |
|
Permissive
Robust
|
Homo sapiens |
GSE73207
|
MA0036.3
|
GATA2 |
CD34+ cells |
ACY957 |
Permissive
Robust
|
Homo sapiens |
GSE60792
|
MA0036.3
|
GATA2 |
CD34+ cells |
DMSO |
Permissive
Robust
|
Homo sapiens |
GSE60792
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
CSFCS |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
ETOH |
Permissive
|
Homo sapiens |
GSE69043
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
FBS |
Permissive
Robust
|
Homo sapiens |
GSE69043
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
R1881 |
Permissive
|
Homo sapiens |
GSE69043
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
SHGATA2_ETOH |
Permissive
|
Homo sapiens |
GSE69043
|
MA0036.3
|
GATA2 |
LNCaP (prostate carcinoma) |
SHGATA2_R1881 |
Permissive
|
Homo sapiens |
GSE69043
|
MA0036.3
|